Pitney Bowes Releases Order Experience Index to Help Direct-to-Consumer Retailers Navigate Post-Pandemic Market - Yahoo Finance
Selecta, Sobi rout gout in pair of phase 3 trials that could challenge ... - FierceBiotech
Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Sold by Hennion ... - MarketBeat
Return of the megaround: Is biotech back from the brink? - FierceBiotech
Clario partners with Strados to offer respiratory tech for clinical trials - FierceBiotech
New Study: The Status Epilepticus Market Enhancement in Various ... - Digital Journal
Generalized Anxiety Disorder Market to Register Incremental Growth ... - Digital Journal
News snapshot: Appia Rare Earths & Uranium, BioLargo, First ... - Proactive Investors USA
Gilead scoops up Nurix's IRAK4 degrader for up to $445M, plucking ... - FierceBiotech
Hype builds for Karuna's schizophrenia drug with phase 3 data - FierceBiotech

Pages